Brainfulness Ltd

Brainfulness Ltd. treats major depression using artificial intelligence. Our machine teaches the brain a new language based on AI. As a result, the brain screens the whole body and finds those distorted places in the body, which cause major depression and repairs them. This relatively short-term process heals the patient in considerable percentages. The clinical trial carried out by us confirms all of the above. Founded by two scientists, one with a strong background in medicine and the other in performance education- neuroscience, Brainfulness introduces a new paradigm in Neurobiology based on the idea of “Repetitive Triggered Somatosensory Discrimination.” Our device and software treat anxiety and depression without side effects, without the use of medication, electric shocks, or magnetic fields, and without any need for expensive doctors or hospitalization. In 2015, we conducted a successful open-pilot clinical study with positive results. Participants in the trial included 30 chronic patients who were resistant to previous treatments. Brainfulness has 4 approved patents in Germany, Japan, the US, and Israel and has received approval to use the device on humans from the Israel Ministry of Health and the Helsinki Committee. We are thrilled to welcome Mr. Dan Yalon as our new strategic advisor. With his extensive experience, we are confident that he will help us take Brainfulness to the next level